Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

Descrizione completa

Dettagli Bibliografici
Autori principali: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
Natura: Articolo
Lingua:English
Pubblicazione: Elsevier 2023-12-01
Serie:Biomarkers in Neuropsychiatry
Soggetti:
Accesso online:http://www.sciencedirect.com/science/article/pii/S2666144623000102